For the quarter ending 2026-03-31, OGEN has $7,489,636 in assets. $1,307,878 in debts. $6,107,078 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 6,107,078 | 4,399,726 | 11,403,766 | 1,973,745 |
| Short-term investments | - | 4,000,000 | - | - |
| Interest receivable | - | 53,082 | - | - |
| Prepaid expenses and other current assets | 1,382,558 | 1,614,956 | 1,301,778 | 165,963 |
| Total current assets | 7,489,636 | 10,067,764 | 12,705,544 | 2,139,708 |
| Total assets | 7,489,636 | 10,067,764 | 12,705,544 | 2,139,708 |
| Accounts payable and accrued expenses | 1,251,744 | 1,559,011 | 2,479,272 | 1,267,423 |
| Short-term notes payable, net of debt issuance costs | 56,134 | 227,348 | 394,836 | 3,000,000 |
| Preferred stock, no par value 50,000,000 shares authorized 7,488,692 and 7,488,692 series f outstanding at june 30, 2025, and december 31, 2024, respectively | - | - | - | 0 |
| Total liabilities | 1,307,878 | 1,786,359 | 2,874,108 | 4,267,423 |
| Common stock, 0.001 par value 350,000,000 shares authorized 4,375,729 and 4,271,529 shares issued and outstanding at march 31, 2026, and december 31, 2025, respectively | 4,375 | 4,271 | 4,127 | 823 |
| Additional paid-in capital | 235,007,285 | 234,905,793 | 234,169,098 | 219,146,662 |
| Accumulated deficit | -228,829,902 | -226,628,659 | -224,341,789 | -221,275,200 |
| Total stockholders equity | 6,181,758 | 8,281,405 | 9,831,436 | -2,127,715 |
| Total liabilities and stockholders equity | 7,489,636 | 10,067,764 | 12,705,544 | 2,139,708 |
ORAGENICS INC (OGEN)
ORAGENICS INC (OGEN)